A multiplicative assumption would have merit in our testing against HLA-DRB1 shared epitope and PTPN22, if ACPA-positive RA were a homogeneous set of causes, rather than the kind of heterogeneity of causation that we have shown gives rise to additivity between risk factors. This evidence concerns the gene PRTN3 and rheumatoid arthritis.